Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Sotalol hydrochloride tablets and production technology thereof

A technology of Lool tablet and hydrochloric acid, applied in the field of medicine, can solve the problems of unfavorable product stability, inconvenient industrial production of granulation process, etc., and achieve the effects of fast onset, fast dissolution and good stability

Pending Publication Date: 2020-06-05
LUNAN PHARMA GROUP CORPORATION
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] In the existing sotalol hydrochloride preparations, the tablet preparation process is mainly a wet granulation process, which is affected by humidity and heat factors during the preparation process, which is not conducive to the stability of the product. At the same time, the relatively complicated granulation process It also brings great inconvenience to the industrialized production of products.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sotalol hydrochloride tablets and production technology thereof
  • Sotalol hydrochloride tablets and production technology thereof
  • Sotalol hydrochloride tablets and production technology thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027]

[0028] Preparation Process:

[0029] Sotalol hydrochloride is pulverized through an 80-mesh sieve, mixed evenly with microcrystalline cellulose 102, mannitol 200SD, crospovidone, and silicon dioxide, added with magnesium stearate, mixed, and then compressed into tablets.

Embodiment 2

[0031]

[0032] Preparation process: the components of the auxiliary materials are changed accordingly, and the preparation process is the same as in Example 1.

Embodiment 3

[0034]

[0035] Preparation process: the components of the auxiliary materials are changed accordingly, and the preparation process is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicines, and provides sotalol hydrochloride tablets and a production technology thereof. According to the sotalol hydrochloride tablets and the production technology thereof, accessories of the sotalol hydrochloride tablets and the usages, especially the types of the accessories, are optimized, and the sotalol hydrochloride tablets are produced by conductingcrushing treatment on sotalol hydrochloride, making the crushed sotalol hydrochloride pass through an 80-mesh screen for treatment, and conducting tabletting directly after the crushed screened sotalol hydrochloride and the optimized accessories are mixed evenly. Compared with the prior art, the sotalol hydrochloride tablets and the production technology thereof have the advantages that the production technology is simple, the dissolving-out speed is high, and the medicine stability is good, so that the sotalol hydrochloride tablets are especially suitable for industrial production.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a sotalol hydrochloride tablet and a preparation process thereof. Background technique [0002] Sotalol hydrochloride is the only antiarrhythmic drug that has both β-receptor blockade and class III action potential (ADP) prolongation, and can also be used to treat angina pectoris and hypertension. The drug is a β-receptor blocker developed by Squibb. It was synthesized for the first time in 1960 and was approved by the FDA in 1992. Due to its remarkable curative effect, stable drug effect and few adverse reactions, it has been widely recognized clinically and is Used as a first-line drug for the treatment of sinus rhythm and atrial fibrillation. The chemical name of sotalol hydrochloride is: 4'-(1-hydroxy-2-isopropylaminoethyl) methanesulfonanilide hydrochloride, the structural formula is as follows: [0003] [0004] At present, preparations using sotalol hydrochloride as raw materi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/20A61K31/18A61P9/06A61P9/10A61P9/12
CPCA61K31/18A61K9/2095A61K9/2054A61P9/06A61P9/10A61P9/12
Inventor 张磊杨玲
Owner LUNAN PHARMA GROUP CORPORATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products